Drug induced acute pancreatitis with uninfected necrosis
ICD-10 K85.31 is a billable code used to indicate a diagnosis of drug induced acute pancreatitis with uninfected necrosis.
Drug-induced acute pancreatitis with uninfected necrosis is a severe condition characterized by inflammation of the pancreas due to the adverse effects of certain medications. Clinically, patients may present with severe abdominal pain, nausea, vomiting, and elevated serum amylase and lipase levels. The anatomy involved includes the pancreas, which is located behind the stomach and plays a crucial role in digestion and glucose metabolism. Disease progression can lead to necrosis of pancreatic tissue, which, if uninfected, may not show signs of secondary infection but can still result in significant morbidity. Diagnostic considerations include imaging studies such as CT scans or MRIs to assess the extent of necrosis and rule out complications like infected necrosis or abscess formation. A thorough medication history is essential to identify potential drug triggers, which may include certain antibiotics, diuretics, and immunosuppressants. Early recognition and management are critical to prevent further complications and improve patient outcomes.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
K85.31 specifically covers acute pancreatitis that is induced by drugs, characterized by necrosis of pancreatic tissue without infection. This includes cases where the patient has a history of medication use that is known to cause pancreatitis.
K85.31 should be used when there is clear evidence that acute pancreatitis is caused by a drug, and the patient exhibits necrosis without signs of infection. If the pancreatitis is due to other causes, such as alcohol or gallstones, different codes should be selected.
Documentation should include a detailed medication history, clinical findings consistent with acute pancreatitis, imaging results showing necrosis, and a clear statement linking the drug to the condition.
